Abstract
Antibiotic resistance is rapidly increasing, and new anti-infective therapies are urgently needed. In this regard, antimicrobial peptides (AMPs) may represent potential candidates for the treatment of infections caused by multiresistant microorganisms. In this narrative review, we reported the experience of our research group over 20 years. We described the AMPs we evaluated against Gram-positive, Gram-negative, and fungi. In conclusion, our experience shows that AMPs can be a key option for treating multiresistant infections and overcoming resistance mechanisms. The combination of AMPs allows antibiotics and antifungals that are no longer effective to exploit the synergistic effect by restoring their efficacy. A current limitation includes poor data on human patients, the cost of some AMPs, and their safety, which is why studies on humans are needed as soon as possible.
Reference97 articles.
1. World Health Organization (WHO) (2022, October 13). Antimicrobial Resistance. Available online: https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance.
2. Healthcare Without Harm (HCWH) (2022, October 13). Antimicrobial Resistance in European Medical Schools. Available online: https://noharm-europe.org/sites/default/files/documents-files/6591/2020-11-18-Antimicrobial-resistance-in-European-medical-schools_WEB.pdf.
3. Antimicrobial peptides in reptiles;Pharmaceuticals,2014
4. Plant antimicrobial peptides;Nawrot;Folia Microbiol.,2014
5. Antimicrobial peptides in mammalian and insect host defence;Lehrer;Curr. Opin. Immunol.,1999
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献